Results reassuring on dementia risk from RA drug

And it may even reduce mortality risk

Concerns that hydroxychloroquine may raise the risk of dementia have been allayed by a study that shows no association and suggests the treatment may even reduce mortality in some patients.

Information from a UK primary care database of 11,550 patients with connective tissue disease on long-term treatment with either chloroquine or hydroxychloroquine was compared with data on nearly 31,000 people who had connective tissue disease but were not on these treatments.

Patients with a mean age of 56 years (78% women) were taking the drugs for rheumatoid arthritis